Telomeres and Telomerase
Cell-culture studies have reported changes in telomerase activity and telomere length. These findings do not demonstrate that Epitalon reverses aging or extends human life.
Explore cellular-aging research and personalized guidance for your long-term health goals.
Book Your AppointmentEpitalon, also spelled Epithalon, is a synthetic four-amino-acid peptide explored in cellular-aging research. It was developed from work on epithalamin, a pineal-gland extract; the two are different substances.
Science worth understanding: Epitalon is investigational and not FDA-approved. Interest in its biology has grown, but meaningful benefits and long-term safety in people remain unestablished.
Its appeal comes from questions about how cells age and communicate. These are research areas, rather than proven treatment benefits.

Cell-culture studies have reported changes in telomerase activity and telomere length. These findings do not demonstrate that Epitalon reverses aging or extends human life.
Pineal-peptide research has explored melatonin rhythms. Findings involving different peptides or extracts cannot automatically be attributed to Epitalon.
Laboratory studies examine gene expression, chromatin activity, and cellular responses. Their practical significance for patient care remains uncertain.
A change in a cellular marker is not the same as better health, fewer illnesses, or longer life. Clinical outcomes require studies in people.
Telomeres help protect chromosome ends. Their biology is complex: longer telomeres are not automatically better, and telomerase activity alone is not a measure of healthy aging.

Research in cultured cells—including cancer cell lines—helps generate scientific questions. It does not establish an anti-aging treatment or prove that Epitalon causes or prevents cancer. Potential effects on abnormal cell growth remain an important safety question.
Both appear in telomerase discussions, but they are not interchangeable.

TA-65 is marketed as an Astragalus-derived dietary supplement. Supplement marketing does not establish that a product treats disease or extends lifespan.
Epitalon is a synthetic peptide under investigation. Evidence about an oral supplement cannot validate the safety, effectiveness, or absorption of a peptide preparation.
Product imagery is included for comparison, not as an endorsement or recommendation.
Bring your questions about sleep, recovery, and healthy aging. Our Pasadena team can help you understand the research while focusing on practical steps for your health.

Discuss symptoms, medical history, medications, supplements, and what you hope to improve.
Explore appropriate evaluation and established care options. A research discussion does not require committing to a peptide treatment.
Different delivery methods do not resolve gaps in evidence. Clinical dosing, interactions, and long-term safety have not been established.

Injection, oral, and nasal products should not be assumed equivalent. Absorption and product quality can differ, and injection adds contamination and local-reaction risks.
Pairing Epitalon with DSIP or other longevity-focused compounds does not establish additional benefit. Combination safety and interactions need evidence of their own.
FDA has highlighted concerns about aggregation, peptide impurities, and possible immune reactions, with limited safety information for proposed administration routes.
Discuss cancer history, pregnancy or breastfeeding, and all medications with your clinician. A lack of reported adverse effects does not establish safety.
Clear information about the substance, evidence, and regulatory status matters as much as the source.
FDA compounding advisory review is separate from drug approval. A nomination or committee recommendation does not itself establish final list inclusion or availability.
Any prescribing or compounding must satisfy current requirements. A licensed pharmacy or purity certificate does not establish clinical effectiveness or permission to compound a particular substance.
Compounded drugs are not FDA-approved. This page does not promise access to Epitalon or a future availability date.
Straightforward answers to common research and consultation questions.

No. Epitalon is a synthetic tetrapeptide; epithalamin is a pineal-gland extract containing multiple peptides. Results should not be treated as interchangeable.
Human benefit has not been established. Laboratory findings about telomeres do not demonstrate longer life or improved health in people.
Research has explored pineal peptides and daily rhythms, but Epitalon is not an established insomnia treatment. Persistent sleep difficulties deserve an individualized evaluation.
It raises a biological question, not a confirmed clinical outcome. Long-term human data are insufficient to establish the risk; tell your clinician about any cancer history.
No validated clinical regimen is established. Claims about injections, capsules, or nasal formulations should not be mistaken for approved treatment instructions.
There is no established safety or effectiveness for these combinations. Review all products with your provider rather than following an online stack protocol.
We review your health concerns, explain the evidence, and discuss appropriate care options. A visit does not guarantee an Epitalon prescription.
Eligibility depends on the service, medical necessity, and plan rules. Confirm benefits or account eligibility before assuming an expense is covered.
Meet with our medical team to discuss your goals and identify a practical next step.
Book Your AppointmentThis page is educational and does not replace medical advice. Epitalon is investigational and not FDA-approved. Human benefits and long-term safety remain uncertain; consultation does not establish treatment availability.
These sources include regulatory evaluations and laboratory or exploratory research. They should be interpreted according to their study design.